x

ABVC BIOPHARMA, INC. (Nasdaq:ABVC)

Health Care/Life Sciences • Biotechnology
CIK 1173313
Company

ABVC BioPharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development of new drugs and medical devices. The firm's product pipeline includes ABV-1501, which is a combination therapy for triple negative breast cancer, ABV-1504, which is a botanical reuptake inhibitor that targets norepinephrine, ABV-1505 for treating attention deficit hyperactivity disorder, ABV-1702 to treat myelodysplastic syndromes, ABV-1703 for Pancreatic Cancer, ABV-1601 for treating depression in cancer patients, ABV-1701, which is a vitreous substitute for vitrectomy, ABV-2001, and ABV-2002. The company was founded in 1990 and is headquartered in Fremont, CA.

Address
44370 Old Warm Springs Boulevard
Fremont, California 94538
Employees
23
Stock Info
Close
$1.2100
Day Range
1.2000 - 1.2500
52 Week Range
0.6739 - 9.6000
Average volume
1.76M
Short Interest
120.7K (02/15/24)
% of Float Shorted
1.83%
Market Cap
$10.61M
Revenue
$969.78K
Net Income
-$16.42M
2020 Sales Growth
N/A
Rev. per Employee
$32.14K
P/E Ratio
N/A
EPS
-$3.5464
Yield
N/A
Dividend
N/A
Ex-Dividend Date
N/A
Key Executives
Board Of Directors
SEC filings
DateFormEvent
10 Sep, 2024 8-K
20 Aug, 2024 8-K
16 Aug, 2024 424B4
16 Aug, 2024 424B4
16 Aug, 2024 424B4
15 Aug, 2024 8-K
14 Aug, 2024 10-Q
7 Aug, 2024 424B5
7 Aug, 2024 424B5
1 Aug, 2024 EFFECT
26 Jul, 2024 POS AM
23 Jul, 2024 8-K
12 Jul, 2024 8-K
12 Jul, 2024 424B4
1 Jul, 2024 EFFECT
27 Jun, 2024 CORRESP
26 Jun, 2024 UPLOAD
25 Jun, 2024 8-K/A
24 Jun, 2024 8-K/A
21 Jun, 2024 S-1
28 May, 2024 D
24 May, 2024 8-K
23 May, 2024 424B4
23 May, 2024 8-K
22 May, 2024 424B4
22 May, 2024 424B4
17 May, 2024 10-Q
17 May, 2024 8-K/A
15 May, 2024 8-K
15 May, 2024 NT 10-Q
9 May, 2024 8-K
30 Apr, 2024 EFFECT
26 Apr, 2024 PRE 14A
25 Apr, 2024 POS AM
19 Apr, 2024 8-K
17 Apr, 2024 8-K
5 Apr, 2024 424B4
1 Apr, 2024 EFFECT
29 Mar, 2024 CORRESP
26 Mar, 2024 8-K
25 Mar, 2024 DEFA14A
22 Mar, 2024 S-1/A
15 Mar, 2024 10-K/A
14 Mar, 2024 DEFA14A
14 Mar, 2024 8-K
14 Mar, 2024 8-K
13 Mar, 2024 10-K
29 Feb, 2024 8-K/A
29 Feb, 2024 8-K/A
16 Feb, 2024 CORRESP
16 Feb, 2024 S-1/A
13 Feb, 2024 UPLOAD
13 Feb, 2024 SC 13G/A
9 Feb, 2024 CORRESP
9 Feb, 2024 S-1/A
8 Feb, 2024 8-K
26 Jan, 2024 8-K/A
22 Jan, 2024 UPLOAD
17 Jan, 2024 8-K/A
17 Jan, 2024 8-K
17 Jan, 2024 8-K
12 Jan, 2024 S-1
29 Dec, 2023 DEF 14A
15 Dec, 2023 PRE 14A
20 Nov, 2023 8-K
17 Nov, 2023 424B3
17 Nov, 2023 424B4
17 Nov, 2023 424B4
16 Nov, 2023 8-K
15 Nov, 2023 10-Q
15 Nov, 2023 8-K
14 Nov, 2023 NT 10-Q
13 Sep, 2023 8-K
6 Sep, 2023 8-K/A
31 Aug, 2023 8-K
17 Aug, 2023 8-K
17 Aug, 2023 424B4
17 Aug, 2023 424B3
17 Aug, 2023 424B4
14 Aug, 2023 10-Q
9 Aug, 2023 8-K/A
7 Aug, 2023 8-K
7 Aug, 2023 SC 13G
2 Aug, 2023 8-K
31 Jul, 2023 8-K
31 Jul, 2023 424B5
27 Jul, 2023 8-K
24 Jul, 2023 8-K
7 Jul, 2023 8-K
23 Jun, 2023 8-K CEO Change
21 Jun, 2023 DEF 14A
15 Jun, 2023 8-K
12 Jun, 2023 424B4
9 Jun, 2023 8-K
9 Jun, 2023 8-K
8 Jun, 2023 EFFECT
8 Jun, 2023 S-1/A
7 Jun, 2023 CORRESP
7 Jun, 2023 S-1/A
1 Jun, 2023 CORRESP
1 Jun, 2023 S-1/A
31 May, 2023 PRE 14A
26 May, 2023 8-K
22 May, 2023 424B4
22 May, 2023 424B3
15 May, 2023 10-Q
11 May, 2023 UPLOAD
10 May, 2023 S-1/A
10 May, 2023 CORRESP
3 May, 2023 UPLOAD
1 May, 2023 EFFECT
1 May, 2023 EFFECT
26 Apr, 2023 POS AM
26 Apr, 2023 POS AM
24 Apr, 2023 8-K
24 Apr, 2023 S-1
14 Apr, 2023 DEF 14A
4 Apr, 2023 PRE 14A
3 Apr, 2023 8-K/A
31 Mar, 2023 8-K
31 Mar, 2023 10-K
2 Mar, 2023 D
24 Feb, 2023 8-K
16 Feb, 2023 8-K
15 Nov, 2022 424B3
15 Nov, 2022 424B4
14 Nov, 2022 10-Q
21 Oct, 2022 8-K
13 Sep, 2022 8-K
9 Sep, 2022 8-K
25 Aug, 2022 424B3
25 Aug, 2022 424B4
22 Aug, 2022 8-K
15 Aug, 2022 10-Q
14 Jul, 2022 8-K
12 Jul, 2022 3
12 Jul, 2022 SC 13D
11 Jul, 2022 424B4
11 Jul, 2022 424B3
23 Jun, 2022 EFFECT
23 Jun, 2022 POS AM
21 Jun, 2022 8-K
17 Jun, 2022 EFFECT
14 Jun, 2022 POS AM
14 Jun, 2022 POS AM
9 Jun, 2022 8-K/A
6 Jun, 2022 10-K/A
1 Jun, 2022 8-K
25 May, 2022 8-K
17 May, 2022 8-K
16 May, 2022 424B5
16 May, 2022 10-Q
12 May, 2022 8-K
27 Apr, 2022 DEF 14A
27 Apr, 2022 8-K
31 Mar, 2022 10-K
31 Mar, 2022 3
31 Mar, 2022 8-K
9 Mar, 2022 8-K
22 Feb, 2022 8-K
10 Dec, 2021 3
10 Dec, 2021 3
29 Nov, 2021 EFFECT
24 Nov, 2021 CORRESP
17 Nov, 2021 424B3
17 Nov, 2021 424B3
16 Nov, 2021 S-3/A
15 Nov, 2021 3
15 Nov, 2021 3
15 Nov, 2021 3
15 Nov, 2021 3
15 Nov, 2021 10-Q
15 Nov, 2021 3
5 Nov, 2021 3
5 Nov, 2021 3
5 Nov, 2021 3
4 Nov, 2021 UPLOAD
29 Oct, 2021 S-3
26 Oct, 2021 3
8 Oct, 2021 8-K
13 Aug, 2021 424B3
13 Aug, 2021 424B3
12 Aug, 2021 10-Q
5 Aug, 2021 8-K
4 Aug, 2021 424B4
3 Aug, 2021 S-1MEF
2 Aug, 2021 CERT
2 Aug, 2021 8-A12B
2 Aug, 2021 EFFECT
29 Jul, 2021 CORRESP
29 Jul, 2021 CORRESP
29 Jul, 2021 S-1/A
28 Jul, 2021 S-1/A
21 Jul, 2021 S-1/A
21 Jun, 2021 S-1/A
8 Jun, 2021 8-K/A
14 May, 2021 424B3
14 May, 2021 S-1/A
11 May, 2021 424B4
10 May, 2021 10-Q
3 May, 2021 8-K/A
19 Apr, 2021 EFFECT
15 Apr, 2021 POS AM
13 Apr, 2021 UPLOAD
8 Apr, 2021 S-1
16 Mar, 2021 10-K
11 Feb, 2021 8-K
8 Jan, 2021 8-K
7 Jan, 2021 8-K
22 Dec, 2020 CORRESP
15 Dec, 2020 CORRESP
3 Dec, 2020 UPLOAD
Last update:2024-03-06 12:25:35.126224
ABVC BIOPHARMA, INC. by TradingView

Sign Up to Subscribe